{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:40:27Z","timestamp":1762101627943,"version":"3.40.5"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Angiotensin-converting enzyme 2 (ACE2) is a key enzyme of the renin angiotensin system, which breaks down angiotensin II and forms angiotensin-(1\u20137). In erectile tissues, it has been documented that angiotensin II contributes to the development of erectile dysfunction (ED), while treatment with angiotensin-(1\u20137) improves penile erection. However, the expression and function of ACE2 in erectile tissues have never been investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>Here, we examined the expression of ACE2 in erectile tissues and its actions against hypercholesterolemia-induced corpus cavernosum (CC) injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Hypercholesterolemic apolipoprotein E knockout (ApoE\u2212\/\u2212) mice, a well-known model of ED, were treated with diminazene aceturate (DIZE), an ACE2 activator compound, or vehicle for 3 weeks. Reactive oxygen species (ROS), collagen content, and protein expression of ACE2, neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS), nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) subunits were evaluated in the penis of DIZE-treated and untreated ApoE\u2212\/\u2212 mice. Functional studies were performed in CC strips.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>ACE2 expression and its role in modulating nitric oxide (NO)\/ROS production and fibrosis within the CC of hypercholesterolemic mice were the main outcome measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ACE2 was expressed in smooth muscle and endothelial cells of mouse CC. Interestingly, ACE2 was downregulated in penis of hypercholesterolemic mice with ED, suggesting a protective role of ACE2 on the CC homeostasis. In accordance with that, pharmacological ACE2 activation by DIZE treatment reduced ROS production and NADPH oxidase expression, and elevated nNOS and eNOS expression and NO bioavailability in the penis of ApoE\u2212\/\u2212 mice. Additionally, DIZE decreased collagen content within the CC. These beneficial actions of DIZE on the CC were not accompanied by improvements in atherosclerotic plaque size or serum lipid profile.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ACE2 is expressed in erectile tissue and its reduction is associated with hypercholesterolemia-induced ED. Additionally, treatment with DIZE improved hypercholesterolemia-induced CC injury, suggesting ACE2 as a potential target for treating ED.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jsm.12757","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T07:42:44Z","timestamp":1416469364000},"page":"289-302","source":"Crossref","is-referenced-by-count":22,"title":["Diminazene Protects Corpus Cavernosum Against Hypercholesterolemia-Induced Injury"],"prefix":"10.1093","volume":"12","author":[{"given":"Rodrigo A.","family":"Fraga-Silva","sequence":"first","affiliation":[{"name":"Laboratory of Hemodynamics and Cardiovascular Technology , Lausanne , Switzerland"},{"name":"Institute of Bioengineering , Lausanne , Switzerland"},{"name":"Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne , Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana P.","family":"Costa-Fraga","sequence":"additional","affiliation":[{"name":"Laboratory of Hemodynamics and Cardiovascular Technology , Lausanne , Switzerland"},{"name":"Institute of Bioengineering , Lausanne , Switzerland"},{"name":"Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne , Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , Geneva , Switzerland"},{"name":"Division of Cardiology , Geneva , Switzerland"},{"name":"Foundation for Medical Researches , Geneva , Switzerland"},{"name":"Geneva University Hospitals , Geneva , Switzerland"},{"name":"First Clinic of Internal Medicine , Genoa , Italy"},{"name":"Department of Internal Medicine , Genoa , Italy"},{"name":"University of Genoa , Genoa , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Sturny","sequence":"additional","affiliation":[{"name":"Laboratory of Hemodynamics and Cardiovascular Technology , Lausanne , Switzerland"},{"name":"Institute of Bioengineering , Lausanne , Switzerland"},{"name":"Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne , Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younoss","family":"Faye","sequence":"additional","affiliation":[{"name":"Laboratory of Hemodynamics and Cardiovascular Technology , Lausanne , Switzerland"},{"name":"Institute of Bioengineering , Lausanne , Switzerland"},{"name":"Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne , Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , Geneva , Switzerland"},{"name":"Division of Cardiology , Geneva , Switzerland"},{"name":"Foundation for Medical Researches , Geneva , Switzerland"},{"name":"Geneva University Hospitals , Geneva , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziano","family":"Pelli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , Geneva , Switzerland"},{"name":"Division of Cardiology , Geneva , Switzerland"},{"name":"Foundation for Medical Researches , Geneva , Switzerland"},{"name":"Geneva University Hospitals , Geneva , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayak","family":"Shenoy","sequence":"additional","affiliation":[{"name":"Physiology and Functional Genomics , Gainesville, FL , USA"},{"name":"College of Medicine , Gainesville, FL , USA"},{"name":"University of Florida , Gainesville, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela F.","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics , Belo Horizonte , Brazil"},{"name":"Federal University of Minas Gerais , Belo Horizonte , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan K.","family":"Raizada","sequence":"additional","affiliation":[{"name":"Physiology and Functional Genomics , Gainesville, FL , USA"},{"name":"College of Medicine , Gainesville, FL , USA"},{"name":"University of Florida , Gainesville, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson A.S.","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics , Belo Horizonte , Brazil"},{"name":"Federal University of Minas Gerais , Belo Horizonte , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Stergiopulos","sequence":"additional","affiliation":[{"name":"Laboratory of Hemodynamics and Cardiovascular Technology , Lausanne , Switzerland"},{"name":"Institute of Bioengineering , Lausanne , Switzerland"},{"name":"Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne , Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"2023012309024097900_bb0010","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: Current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2023012309024097900_bb0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9343(02)01241-X","article-title":"Vascular and cardiac benefits of angiotensin receptor blockers","volume":"113","author":"Schiffrin","year":"2002","journal-title":"Am J Med"},{"key":"2023012309024097900_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11906-012-0324-1","article-title":"Opportunities for targeting the Angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/mas receptor pathway in hypertension","volume":"15","author":"Fraga-Silva","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"2023012309024097900_bb0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0090-4295(01)01312-7","article-title":"Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction","volume":"58","author":"Becker","year":"2001","journal-title":"Urology"},{"key":"2023012309024097900_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0090-4295(00)00881-5","article-title":"Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence","volume":"57","author":"Becker","year":"2001","journal-title":"Urology"},{"key":"2023012309024097900_bb0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1113\/expphysiol.2012.068551","article-title":"AVE 0991, a non-peptide Mas-receptor agonist, facilitates penile erection","volume":"98","author":"da Costa Goncalves","year":"2013","journal-title":"Exp Physiol"},{"key":"2023012309024097900_bb0040","doi-asserted-by":"crossref","first-page":"H2588","DOI":"10.1152\/ajpheart.00173.2007","article-title":"Evidence that the vasodilator angiotensin-(1\u20137)-Mas axis plays an important role in erectile function","volume":"293","author":"da Costa Goncalves","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023012309024097900_bb0045","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0022-5347(01)64901-2","article-title":"Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum","volume":"157","author":"Kifor","year":"1997","journal-title":"J Urol"},{"key":"2023012309024097900_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.phrs.2007.05.008","article-title":"Different responses to angiotensin-(1\u20137) in young, aged and diabetic rabbit corpus cavernosum","volume":"56","author":"Yousif","year":"2007","journal-title":"Pharmacol Res"},{"key":"2023012309024097900_bb0055","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/eci.12117","article-title":"Pathophysiological role of the renin-angiotensin system on erectile dysfunction","volume":"43","author":"Fraga-Silva","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"2023012309024097900_bb0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-5347(01)64577-4","article-title":"Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors","volume":"158","author":"Park","year":"1997","journal-title":"J Urol"},{"key":"2023012309024097900_bb0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1743-6109.2007.00733.x","article-title":"NADPH oxidase activation: A mechanism of hypertension-associated erectile dysfunction","volume":"5","author":"Jin","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309024097900_bb0070","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH12-06-0396","article-title":"The angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/Mas receptor axis: A potential target for treating thrombotic diseases","volume":"108","author":"Fraga-Silva","year":"2012","journal-title":"Thromb Haemost"},{"key":"2023012309024097900_bb0075","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"2023012309024097900_bb0080","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"2023012309024097900_bb0085","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hernandez Prada","year":"2008","journal-title":"Hypertension"},{"key":"2023012309024097900_bb0090","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/HYPERTENSIONAHA.111.00627","article-title":"Angiotensin-converting enzyme 2 activation improves endothelial function","volume":"61","author":"Fraga-Silva","year":"2013","journal-title":"Hypertension"},{"key":"2023012309024097900_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Fraga-Silva","year":"2010","journal-title":"Mol Med"},{"key":"2023012309024097900_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1113\/expphysiol.2010.055277","article-title":"Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases","volume":"96","author":"Ferreira","year":"2011","journal-title":"Exp Physiol"},{"key":"2023012309024097900_bb0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1164\/rccm.201205-0880OC","article-title":"Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models","volume":"187","author":"Shenoy","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2023012309024097900_bb0110","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","article-title":"Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology","volume":"62","author":"Qi","year":"2013","journal-title":"Hypertension"},{"key":"2023012309024097900_bb0115","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Exp Physiol"},{"key":"2023012309024097900_bb0120","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1167\/iovs.12-11427","article-title":"Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2","volume":"54","author":"Foureaux","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023012309024097900_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2013.04.017","article-title":"Diminazene aceturate improves autonomic modulation in pulmonary hypertension","volume":"713","author":"Rigatto","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"4 Pt 1","key":"2023012309024097900_bb0130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1743-6109.2007.00518.x","article-title":"A mouse model of hypercholesterolemia-induced erectile dysfunction","volume":"4","author":"Xie","year":"2007","journal-title":"J Sex Med"},{"key":"2023012309024097900_bb0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1476-5381.2011.01267.x","article-title":"Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis","volume":"163","author":"Schlimmer","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2023012309024097900_bb0140","doi-asserted-by":"crossref","first-page":"263846","DOI":"10.1155\/2013\/263846","article-title":"Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice","volume":"2013","author":"Fraga-Silva","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2023012309024097900_bb0145","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1111\/j.1743-6109.2010.01880.x","article-title":"Hypercholesterolemia-induced erectile dysfunction: Endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase","volume":"7","author":"Musicki","year":"2010","journal-title":"J Sex Med"},{"issue":"suppl 4","key":"2023012309024097900_bb0150","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.ijir.3900567","article-title":"The worldwide prevalence and epidemiology of erectile dysfunction","volume":"12","author":"McKinlay","year":"2000","journal-title":"Int J Impot Res"},{"key":"2023012309024097900_bb0155","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1111\/j.1743-6109.2011.02505.x","article-title":"Investigative models in erectile dysfunction: A state-of-the-art review of current animal models","volume":"8","author":"Chung","year":"2011","journal-title":"J Sex Med"},{"key":"2023012309024097900_bb0160","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1111\/jsm.12262","article-title":"An oral formulation of angiotensin-(1\u20137) reverses corpus cavernosum damages induced by hypercholesterolemia","volume":"10","author":"Fraga-Silva","year":"2013","journal-title":"J Sex Med"},{"key":"2023012309024097900_bb0165","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0090-4295(01)00974-8","article-title":"Effect of experimental hypercholesterolemia on cavernosal structures","volume":"57","author":"Yesilli","year":"2001","journal-title":"Urology"},{"key":"2023012309024097900_bb0170","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jsm.12482","article-title":"An increased arginase activity is associated with corpus cavernosum impairment induced by hypercholesterolemia","volume":"11","author":"Fraga-Silva","year":"2014","journal-title":"J Sex Med"},{"key":"2023012309024097900_bb0175","first-page":"11","article-title":"Mouse models of atherosclerosis","author":"Maganto-Garcia","year":"2012","journal-title":"Current protocols in immunology"},{"key":"2023012309024097900_bb0180","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1476-5381.2011.01267.x","article-title":"Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis","volume":"163","author":"Schlimmer","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"suppl 4","key":"2023012309024097900_bb0185","first-page":"231","article-title":"An oral formulation of angiotensin-(1\u20137) protects against hypercholesterolemic-induced corpus cavernosum damages","volume":"9","author":"Fraga-Silva","year":"2012","journal-title":"J Sex Med"},{"key":"2023012309024097900_bb0190","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.108.140533","article-title":"Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan","volume":"327","author":"Baumhakel","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2023012309024097900_bb0195","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.200912-1840OC","article-title":"The angiotensin-converting enzyme 2\/angiogenesis-(1\u20137)\/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension","volume":"182","author":"Shenoy","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2023012309024097900_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2012.08.018","article-title":"Angiotensin converting enzyme 2 and atherosclerosis","volume":"226","author":"Wang","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2A","key":"2023012309024097900_bb0205","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am J Cardiol"},{"key":"2023012309024097900_bb0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.jhh.1000638","article-title":"The importance of the renin-angiotensin system in cardiovascular disease","volume":"12","author":"Nicholls","year":"1998","journal-title":"J Hum Hypertens"},{"key":"2023012309024097900_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3565(24)29349-6","article-title":"Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum","volume":"298","author":"Iwamoto","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"2023012309024097900_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0100-879X2005000400003","article-title":"Cardiovascular actions of angiotensin-(1\u20137)","volume":"38","author":"Ferreira","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"2023012309024097900_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.109.140145","article-title":"Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases","volume":"55","author":"Ferreira","year":"2010","journal-title":"Hypertension"},{"key":"2023012309024097900_bb0230","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00109-008-0336-0","article-title":"Update on tissue renin-angiotensin systems","volume":"86","author":"Bader","year":"2008","journal-title":"J Mol Med"},{"key":"2023012309024097900_bb0235","first-page":"147825","article-title":"New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/mas receptor axis","volume":"2012","author":"Ferreira","year":"2012","journal-title":"Int J Hypertens"},{"key":"2023012309024097900_bb0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11906-012-0324-1","article-title":"Opportunities for targeting the angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/mas receptor pathway in hypertension","volume":"15","author":"Fraga-Silva","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"6 suppl","key":"2023012309024097900_bb0245","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/j.1939-4640.2003.tb02743.x","article-title":"Endothelial dysfunction in erectile dysfunction: Role of the endothelium in erectile physiology and disease","volume":"24","author":"Bivalacqua","year":"2003","journal-title":"J Androl"},{"key":"2023012309024097900_bb0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01294663","article-title":"Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits","volume":"25","author":"Kim","year":"1997","journal-title":"Urol Res"},{"key":"2023012309024097900_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(17)37759-5","article-title":"Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle","volume":"146","author":"Azadzoi","year":"1991","journal-title":"J Urol"},{"key":"2023012309024097900_bb0260","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1590\/S0100-879X2002000900001","article-title":"Recent advances in angiotensin II signaling","volume":"35","author":"Touyz","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"2023012309024097900_bb0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/hr.2010.235","article-title":"ACE2-angiotensin-(1\u20137)-Mas axis and oxidative stress in cardiovascular disease","volume":"34","author":"Rabelo","year":"2011","journal-title":"Hypertens Res"},{"key":"2023012309024097900_bb0270","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/HYPERTENSIONAHA.107.102764","article-title":"Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice","volume":"51","author":"Xu","year":"2008","journal-title":"Hypertension"},{"key":"2023012309024097900_bb0275","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1378650","article-title":"Nitric oxide: A physiologic mediator of penile erection","volume":"257","author":"Burnett","year":"1992","journal-title":"Science"},{"key":"2023012309024097900_bb0280","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/HJH.0b013e32835ecbe5","article-title":"Prolonged treatment with angiotensin 1\u20137 improves endothelial function in diet-induced obesity","volume":"31","author":"Beyer","year":"2013","journal-title":"J Hypertens"},{"key":"2023012309024097900_bb0285","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.HYP.0000174594.17052.33","article-title":"Short-term angiotensin(1\u20137) receptor MAS stimulation improves endothelial function in normotensive rats","volume":"46","author":"Faria-Silva","year":"2005","journal-title":"Hypertension"},{"key":"2023012309024097900_bb0290","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/CIRCULATIONAHA.105.590018","article-title":"Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress","volume":"113","author":"Cheng","year":"2006","journal-title":"Circulation"},{"key":"2023012309024097900_bb0295","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1073\/pnas.1001253107","article-title":"Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023012309024097900_bb0300","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/ATVBAHA.108.164715","article-title":"Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis","volume":"28","author":"Dong","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515309140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515309140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/2\/289\/48625128\/jsm_12_2_289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/2\/289\/48625128\/jsm_12_2_289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:48:11Z","timestamp":1747165691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/12\/2\/289\/6980230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,1]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12757","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"type":"electronic","value":"1743-6109"},{"type":"print","value":"1743-6095"}],"subject":[],"published-other":{"date-parts":[[2015,2]]},"published":{"date-parts":[[2015,2,1]]}}}